Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia, a common condition related to...
Vous n'êtes pas connecté
Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.
Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia, a common condition related to...
Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the risk of developing type 2...
Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the risk of developing type 2...
WEDNESDAY, Sept. 25, 2024 -- For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly...
WEDNESDAY, Sept. 25, 2024 -- In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the...
A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 diabetes could make a big...
Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.
Researchers from the University of Maryland have discovered that antacids, commonly used to treat heartburn and indigestion, may also be beneficial...
Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...